[Federal Register: December 30, 2002 (Volume 67, Number 250)]
[Notices]
[Page 79637]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30de02-100]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Vaccine Advisory Committee, Subcommittee on Future
Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on
Vaccine Safety and Communication Meetings
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Federal advisory committee
meetings.
Name: National Vaccine Advisory Committee (NVAC).
Times and Dates: 9 a.m.-5 p.m., February 4, 2003; 8:30 a.m.-3
p.m., February 5, 2003.
Place: Hubert H. Humphrey Building, Room 705A, 200 Independence
Avenue, SW., Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Notice: In the interest of security, the Department has
instituted stringent procedures for entrance to the Hubert H.
Humphrey Building by non-government employees. Thus, persons without
a government identification card should plan to arrive at the
building each day either between 8 a.m. and 8:30 a.m. or 12:30 p.m.
and 1 p.m. Entrance to the meeting at other times during the day
cannot be assured.
Purpose: This committee advises and makes recommendations to the
Director of the National Vaccine Program on matters related to the
Program responsibilities.
Matters to be Discussed: Agenda items will include: a report
from the National Vaccine Program Office (NVPO) and the Interagency
Vaccine Workgroup; a report from the Assistant Secretary for Health;
a discussion of homeland security and the role of vaccines; an
update on the status of the smallpox vaccination program; an update
on vaccine supply; an update on compensation for vaccine
administration: Centers for Medicare and Medicaid Services Ruling; a
report from the NVAC Workgroup on Public Health Options for
Implementing Immunization Requirements; a report from the Institute
of Medicine (IOM) regarding SV-40; a discussion of the Department of
Health and Human Services global health agenda; an update on polio
eradication and polio laboratory containment; a discussion of the
Homeland Security Act; reports from the Vaccine Safety and
Communication Subcommittee, Immunization Coverage Subcommittee, and
the Future Vaccines Subcommittee; and, reports from the Advisory
Commission on Childhood Vaccines/Division of Vaccine Injury
Compensation, Vaccine Related Biological Products Advisory
Committee/Food and Drug Administration, Advisory Committee on
Immunization Practices/National Immunization Program/National Center
for Infectious Diseases.
Name: Subcommittee on Future Vaccines.
Time and Date: 3:15 p.m.-5 p.m., February 4, 2003.
Place: Hubert H. Humphrey Building, Room 405A, 200 Independence
Avenue, SW., Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee develops policy options and guides
national activities that lead to accelerated development, licensure,
and the best use of new vaccines in the simplest possible
immunization schedules.
Matters to be Discussed: Agenda items include an update on
planning for a workshop on Pneumococcal Disease Prevention in
Adults; discussion of pertussis vaccine strategies; and, a
discussion of future vaccine technologies.
Name: Subcommittee on Immunization Coverage.
Time and Date: 3:15 p.m.-5 p.m., February 4, 2003.
Place: Hubert H. Humphrey Building, Room 705A, 200 Independence
Avenue, SW., Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee will identify and propose solutions
that provide a multifaceted and holistic approach to reducing
barriers that result in low immunization coverage for children.
Matters to be Discussed: Agenda items will include an update on
Publication of Adult and Pediatric Standards; presentation of the
draft report from the Workgroup on Public Health Options for
Implementing Immunization Recommendations; an update on the status
of the IOM report on vaccine financing; a discussion of creative
methods for funding immunization registries; a review of adolescent
coverage rates; and, areas of focus for unmet needs funding.
Name: Subcommittee on Vaccine Safety and Communication.
Time and Date: 3:15 p.m.-5 p.m., February 4, 2003.
Place: Hubert H. Humphrey Building, Room 425A, 200 Independence
Avenue, SW., Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee reviews issues relevant to vaccine
safety and adverse reactions to vaccines.
Matters to be Discussed: Items to be discussed include a report
from the IOM Vaccine Safety Review Committee on future activities
and risk communication recommendations; a follow-up of the NVPO Risk
Communication Workshop; and, a discussion of the smallpox vaccine
communication plan.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Gloria Sagar, Committee
Management Specialist, NVPO, CDC, 4700 Buford Highway M/S K-77,
Chamblee, Georgia 30341, telephone 770/488-2040.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: December 20, 2002.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 02-32864 Filed 12-27-02; 8:45 am]
BILLING CODE 4163-18-P